Specify a stock or a cryptocurrency in the search bar to get a summary
Zhejiang CONBA Pharmaceutical Co Ltd
600572Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, manufacturing, and sales of medicines and general health products in China. It offers Chinese herbal decoction pieces, Chinese patent medicines, chemical pharmaceutical products, chemical raw materials, medical devices, and biological products. The company also provides pharmaceutical dosage forms, including tablets, capsules, pills, dripping pills, granules, powders, injections, freeze-dried powder injections, oral liquids, syrups, nasal drops, ointments, etc. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1993 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd. Address: Binjiang Science and Technology Economic Park, Hangzhou, China, 310052
Analytics
WallStreet Target Price
45.85 CNYP/E ratio
24.8421Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600572
Dividend Analytics 600572
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
21 %Dividend History 600572
Stock Valuation 600572
Financials 600572
Results | 2019 | Dynamics |